JUNO THERAPEUTICS, INC.
SEATTLE, WA

JUNO THERAPEUTICS, INC., SEATTLE

It’s an audacious mission—a quest to radically change the course of medicine. We’re aligning our investments in scientific research, manufacturing – and most of all, people – to change the way cancer and other serious diseases are treated. To all Juno Therapeutics website visitors: Juno Therapeutics is proud to announce it is now a Celgene company. If you would like to access information about Juno and its products and pipeline, please click here: Juno Therapeutics GMBH – Gottingen, Germany Rudolf-Wissell-Straße 28 37079 Juno Therapeutics GMBH – Munich, Germany

KEY FACTS ABOUT JUNO THERAPEUTICS, INC.

Company name
JUNO THERAPEUTICS, INC.
Status
Active
Filed Number
F17000002386
FEI Number
463656275
Date of Incorporation
May 25, 2017
Age - 8 years
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://junotherapeutics.com
Phones
(206) 582-1600

JUNO THERAPEUTICS, INC. NEAR ME

Principal Address
400 DEXTER AVENUE NORTH,
SEATTLE,
WA,
98109,
US

See Also

Officers and Directors

The JUNO THERAPEUTICS, INC. managed by the three persons from SEATTLE on following positions: DIRE

Sandra Ramos-Alves

Position
DIRE Active
From
SEATTLE, WA, 98109

Kimberly M. Jablonski

Position
DIRE Active
From
SEATTLE, WA, 98109

Sophia Park

Position
DIRE Active
From
SEATTLE, WA, 98109





Registered Agent is C T CORPORATION SYSTEM

Address
1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL, 33324

Annual Reports

2023
April 26, 2023
2022
April 23, 2022